ARMO BioSciences' Series C - II Round

ARMO BioSciences raised a round of funding on August 29, 2017.

ARMO BioSciences is focused on developing immunotherapies for the treatment of cancer, fibrosis, hypercholesterolemia/atherosclerosis and inflammatory diseases. ARMO believes that by harnessing the bo…

Articles about ARMO BioSciences' Series C - II Round: